T. Rowe Price Associates’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
Other funds holding IMI
RCM
BRF
EM
RAM
DC
BCM
T. Rowe Price Associates's IMI Position: Q1 2019 in Review
T. Rowe Price Associates sold out of Intermolecular, Inc. (IMI) in Q1 2019, closing a stake of 156,015 shares — an estimated $158K sold.
T. Rowe Price Associates first reported a position in IMI in Q2 2013 and held it in 20 quarters. The position peaked at $2.88M in Q3 2013. 28 funds tracked by Wall St. Rank hold IMI as of Q1 2019.
- T. Rowe Price Associates reported no remaining Intermolecular, Inc. position as of Q1 2019 after selling out during the quarter.
- T. Rowe Price Associates sold 156,015 Intermolecular, Inc. shares in Q1 2019, an estimated $158K.
- T. Rowe Price Associates first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 20 quarters.
- T. Rowe Price Associates's Intermolecular, Inc. position peaked at $2.88M in Q3 2013.
- 28 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2019.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.